The Food and Drug Administration has updated its safety communication pertaining to the June 2021 recall of millions of Philips breathing machines from Philips Respironics designed to aid patients with obstructive sleep apnea.
The agency now says the number of “new replacement devices and repair kits” that the company has actually shipped to US consumers is “considerably less” than the 2.5 million claimed on the company’s